Skip to main content

Advertisement

Log in

von Hippel–Lindau disease type 2A in a family with a duplicated 21-base-pair in-frame insertion mutation in the VHL gene

  • Short Communication
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

von Hippel–Lindau disease (VHL), also called angiomatosis retinae, is inherited as an autosomal dominant trait. It is frequently associated with other tumors in the central nervous system, kidneys, or adrenal glands. In order to investigate the relationship between genotype and corresponding phenotypes, we performed molecular genetic analysis in a Japanese patient with VHL type 2A.

Methods

After informed consent had been obtained, the three exons of the VHL gene were PCR-amplified and sequenced either directly or after subcloning. Clinical features were also examined.

Results

A novel in-frame duplication of the 21 base pairs at nucleotide 806 (the position of codon 198) of the VHL gene was found in our patient. The clinical phenotype of the patient included retinal hemangiomas associated with vitreous hemorrhage and traction retinal detachment, pheochromocytoma, and hemangioma-like lesions in the cerebellum which corresponded to those of VHL type 2A. Abnormal diffuse vascular leakage was observed in the apparently intact retina by fluorescein angiography.

Conclusion

An insertion mutation of the VHL gene is a rare association with VHL type 2. This insertion mutation may interfere the binding between the VHL gene and elongins. Abnormal retinal vascular leakage suggests the possible effects of overexpressed vascular permeability factors such as vascular endothelial growth factor from hemangiomas associated with defective VHL gene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.

References

  1. Chan CC, Vortmeyer AO, Chew EY, et al (1999) VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma. Arch Ophthalmol 117:625–630

    CAS  PubMed  Google Scholar 

  2. Iliopoulos O, Levy AP, Jiang C, Kaelin WG Jr, Goldberg MA (1996) Negative regulation of hypoxia-inducible genes by the von Hippel–Lindau protein. Proc Natl Acad Sci USA 93:10595–10599

    CAS  PubMed  Google Scholar 

  3. Kishida T, Stackhouse TM, Chen F, Lerman MI, Zbar B (1995) Cellular proteins that bind the von Hippel–Lindau disease gene product: mapping of binding domains and the effect of missense mutations. Cancer Res 55:4544–4548

    CAS  PubMed  Google Scholar 

  4. Latif F, Tory K, Gnarra J, et al (1993) Identification of the von Hippel–Lindau disease suppressor gene. Science 260:1317–1320

    CAS  PubMed  Google Scholar 

  5. Niemelä M, Lemeta S, Sainto M, et al (2000) Hemangioblastomas of the retina: impact of von Hippel–Lindau disease. Invest Ophthalmol Vis Sci 41:1909–1915

    PubMed  Google Scholar 

  6. Zbar B, Kishida T, Chen F, et al (1996) Germline mutations in the von Hippel–Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat 8:348–357

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported in part by grants from Karoji Memorial Medical Research Funds, Hirosaki, Japan (Dr. Nakazawa); Grants-in-Aid for Scientific Research B-12557145 and B-11470361 (Dr. Nakazawa) from the Ministry of Education, Culture, Sports, Science, and Technology, Tokyo, Japan; and the the Research Committee on Chorioretinal Degenerations and Optic Atrophy, Ministry of Health, Welfare, and Labor, Tokyo, Japan (Dr. Nakazawa).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mitsuru Nakazawa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miyagawa, Y., Nakazawa, M., Noda, Y. et al. von Hippel–Lindau disease type 2A in a family with a duplicated 21-base-pair in-frame insertion mutation in the VHL gene. Graefe's Arch Clin Exp Ophthalmol 241, 241–244 (2003). https://doi.org/10.1007/s00417-003-0631-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-003-0631-y

Keywords

Navigation